Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes

Edoardo Mannucci; Caterina Lamanna

doi:10.2147/JRLCR.S6345

open access to scientific and medical research

Back to Archived Journals » Journal of Receptor, Ligand and Channel Research » Volume 3

Review

Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes

Total article views		HTML views	PDF downloads	Totals
14,409	Dovepress*	14,409+	3,157	17,566
14,409	Totals	14,409	3,157	17,566
*Since 23 September 2010 +Since July 2016

View citations on Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.